Cost Effectiveness and Resource Allocation

Papers
(The TQCC of Cost Effectiveness and Resource Allocation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan60
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness38
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?29
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer27
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis26
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial24
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi23
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency22
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea22
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening21
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran19
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique18
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis18
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China18
Temporal trend of comorbidity and increasing impacts on mortality, length of stay, and hospital costs of first stroke in Tianjin, North of China18
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model15
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model15
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”14
Economic burden of knee joint replacement in Iran14
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia13
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value13
How a thrombectomy service can reduce hospital deficit: a cost-effectiveness study12
A systemmatic literature review on indirect costs of women with breast cancer12
Cost-effectiveness analysis of surgical proximal femur fracture prevention in elderly: a Markov cohort simulation model12
Understanding the impact of unequal utilization of medical services on the consumption of resources in hemophilia12
Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China12
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study12
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients11
Operationalizing game-theoretic weighting in public hospital cost control: an implementation framework from Chinese tertiary hospitals11
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study in 202111
Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study11
Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports10
The effect of hospital budgeting system on physician-executives’ budget cognitive consciousness and medical decision making10
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?10
The importance and effectiveness of nutritional counselling in patients with autoimmune thyroid diseases in Poland10
Assessing diagnosis-related groups based direct medical expenditures of chronic disease patients in general hospital of lower southern Thailand9
Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality9
IAPN: a simple framework for evaluating whether a population-based risk stratification tool will be cost-effective before implementation9
A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma9
The cost of delivering COVID-19 vaccines in four districts in Malawi9
The stochastic frontier analysis technique in measuring the technical and economic efficiency of hospital diagnostic laboratories: a case study in Iran9
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer9
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—20239
A gender perspective of smoking cessation’s health and economic value in Jordanian women: using cost effectiveness model9
Analysis of costs in implementing the HEARTS hypertension program in Nigerian primary care9
The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission8
Regional disparities, dynamic evolution, and spatial spillover effects of medical resource allocation efficiency in TCM hospitals8
Review for cost-effectiveness analysis of laparoscopic Intra-peritoneal Onlay Mesh for ventral hernia repair in Indian settings8
Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States8
What are economic costs and when should they be used in health economic studies?8
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective8
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases8
Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda8
Factors influencing the demand for individual voluntary private health insurance in Iran7
From pilot to national roll-out of the improved Community Health Fund (iCHF) in Tanzania: lessons learnt and way forward7
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study7
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma7
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran7
The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas7
Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments7
A cost-benefit analysis of mass prostate cancer screening7
Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer7
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier7
Cost utility and budget impact analysis of dexamethasone compared with bortezomib and lenalidomide for the treatment of second line multiple myeloma from a South African public health perspective7
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer7
Household catastrophic health expenditure and its effective factors: a case of Iran7
Risk factors associated with postoperative complications after liver cancer resection surgery in western China7
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method7
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning7
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?6
Population ageing and sustainability of healthcare financing in China6
Comparative Efficiency Analysis of OECD Health Systems: FDH vs. Machine Learning Approaches with Efficiency Analysis Trees (EAT and RFEAT)6
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis6
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis6
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye6
Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting6
The role of routine chest radiography after implantable venous access port catheter insertion under the guide of ultrasonography and fluoroscopy6
Cost-effectiveness analysis of COVID-19 tests in the unified health system6
Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial6
Costs of fall injuries in the STRIDE study: an economic evaluation of healthcare system heterogeneity and heterogeneity of treatment effect6
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review6
Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial–actuarial approach6
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis5
Correction to: Medical expenses and its determinants in female patients with urological disorder5
Cost-effectiveness analysis of robot-assisted gait training in patients with bilateral spastic cerebral palsy5
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting5
Economic burden of breast cancer: a case of Southern Iran5
Strategic analysis of financing communicable diseases in Afghanistan5
Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS)5
Willingness to join community-based health insurance and associated factors among households in Ethiopian: a systematic review and meta-analysis5
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru5
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China5
The burden of health expenditure on household impoverishment in Ethiopia: a systematic review and meta-analysis5
Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia5
Neural networks and hospital length of stay: an application to support healthcare management with national benchmarks and thresholds5
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review5
The value of admission avoidance: cost-consequence analysis of one-year activity in a consolidated service5
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making5
Out-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses5
Impact of including productivity costs in economic analyses of vaccines for C. difficile infections and infant respiratory syncytial virus, in a UK setting5
0.14710402488708